Christopher Krawtschuk

Chief Financial Officer, bluebird bio.

Companies

EAGLE PHARMACEUTICALS, INC.Chief financial officer Nov 19, 2024 to Nov 19, 2024¹
bluebird bioChief financial officer Nov 7, 2022 to Jun 13, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

bluebird bio BLUE45,474 shares³Dec 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 6, 2023Sold 4,526 shares at $4.52 of bluebird bio³
Dec 1, 2022Granted 50,000 shares of bluebird bio⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREAGLE PHARMACEUTICALS, INC., Chief financial officer
2
SEC EDGARbluebird bio, Chief financial officer
3
SEC EDGARbluebird bio shares after the filing of Dec 6, 2023
4
SEC EDGARForm 4 filed Dec 5, 2022